Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases

Clinical trial NCT06953843 · RECRUITING

Trial details

NCT number: NCT06953843
Sponsor: Xinqiao Hospital of Chongqing
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Stage IV Without EGFR/ALK Mutation

Start date: 2025-07-09
Primary completion: 2027-06-30
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.